West Pharmaceutical Services | WST - Sales Revenues

Stock Price
231.62
Daily Change
-5.43 -2.29%
Monthly
-17.52%
Yearly
-29.91%
Q1 Forecast
224.00

West Pharmaceutical Services reported $804.6M in Sales Revenues for its fiscal quarter ending in September of 2025.





Sales Change Date
Align Technology USD 1.05B 54.3M Dec/2025
Avanos Medical USD 177.8M 2.8M Sep/2025
Baxter International USD 2.84B 30M Sep/2025
Becton, Dickinson and Co. USD 5.9B 400M Sep/2025
Charles River Laboratories USD 1000M 32.14M Sep/2025
Cooper Companies USD 1.07B 4.9M Sep/2025
Dentsply International USD 904M 32M Sep/2025
Haemonetics USD 338.97M 11.97M Dec/2025
ICU Medical USD 537M 11.9M Sep/2025
Insulet USD 706.3M 57.2M Sep/2025
Integra LifeSciences USD 402.06M 13.54M Sep/2025
IQVIA Holdings USD 4.36B 260M Dec/2025
J&J USD 24.6B 610M Dec/2025
Medtronic USD 8.96B 383M Sep/2025
Merit Medical Systems USD 384.2M 1.7M Sep/2025
Neogen USD 224.69M 15.5M Sep/2025
Quidel USD 700M 86M Sep/2025
Repligen USD 189M 7M Sep/2025
Solventum Corp USD 2.1B 60M Sep/2025
STAAR Surgical USD 94.7M 50.4M Sep/2025
Terumo JPY 274.97B 15B Sep/2025
West Pharmaceutical Services USD 804.6M 38.1M Sep/2025